Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 16 composition records across product categories including Food and drug, Personal care.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 · limited confidence.
Prevalence of PROPYLENE GLYCOL ALGINATE in our catalog (epa_cpdat).
Products
16
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 16 composition records across product categories including Food and drug, Personal care. EPA CPDat classifies this chemical for functional uses including Binder, Viscosity modifier, Thickening agent.
US
FDA
Route: ORAL; Dosage form: EMULSION; Potency: 0.15 mg/1ml
US
FDA
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Potency: NA
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 2716 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Potency: 0.15 mg/1ml
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 80 mg
US
FDA
openFDA substance registry classifies this ingredient as polymer.